Alchemab Therapeutics Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Alchemab Therapeutics Ltd's estimated annual revenue is currently $5.1M per year.
- Alchemab Therapeutics Ltd's estimated revenue per employee is $77,500
- Alchemab Therapeutics Ltd's total funding is $83M.
Employee Data
- Alchemab Therapeutics Ltd has 66 Employees.
- Alchemab Therapeutics Ltd grew their employee count by -19% last year.
Alchemab Therapeutics Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | Chief Corporate Development and Strategy Officer | Reveal Email/Phone |
4 | Head Finance | Reveal Email/Phone |
5 | SVP Development | Reveal Email/Phone |
6 | SVP Rsearch | Reveal Email/Phone |
7 | Head Operations | Reveal Email/Phone |
8 | Head Translational and Clinical Sciences | Reveal Email/Phone |
9 | VP Technology | Reveal Email/Phone |
10 | Director Neuroscience | Reveal Email/Phone |
Alchemab Therapeutics Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | -12% | N/A | N/A |
#2 | $16.3M | 105 | 4% | N/A | N/A |
#3 | $107.2M | 494 | 25% | $292M | N/A |
#4 | $2.6M | 830 | 30% | $631.7M | N/A |
#5 | $18.1M | 117 | -8% | $81M | N/A |
#6 | $1.2M | 271 | 12% | $440M | N/A |
#7 | $54.6M | 282 | 0% | $132.9M | N/A |
#8 | $9.3M | 60 | -37% | N/A | N/A |
#9 | $21.2M | 137 | 12% | N/A | N/A |
#10 | $408.2M | 1646 | 11% | £994.6M | N/A |
What Is Alchemab Therapeutics Ltd?
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.
keywords:N/A
$83M
Total Funding
66
Number of Employees
$5.1M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alchemab Therapeutics Ltd News
Alchemab to collaborate with AstraZeneca to use Alchemab’s drug discovery platform for prostate cancer study 05-05-2021 Alchemab, a biotech company developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, has formed a co ...
Alchemab to collaborate with AstraZeneca to use Alchemab’s drug discovery platform for prostate cancer study 05-05-2021 Alchemab, a biotech company developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, has formed a co ...
Alchemab to collaborate with AstraZeneca to use Alchemab’s drug discovery platform for prostate cancer study 05-05-2021 Alchemab, a biotech company developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, has formed a co ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.3M | 66 | 27% | $2M |
#2 | $14.4M | 66 | -21% | N/A |
#3 | $35M | 66 | -62% | N/A |
#4 | $14.4M | 66 | -7% | N/A |
#5 | $7.5M | 66 | 2% | N/A |